38 results
Page 2 of 2
6-K
maazd2jfb e4u9
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
n2in mfgb
30 Nov 22
Current report (foreign)
6:28am
6-K
EX-99.1
p1wvgtl
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
3zjh cssej9lfu6yj
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
zqj2f0vfus7r4
28 Jul 22
Current report (foreign)
6:09am
6-K
EX-99.1
yb9uv3
31 May 22
Current report (foreign)
6:14am
6-K
op9fp
1 Nov 21
Current report (foreign)
6:04am
6-K
fmkrp2dh
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
lr0m2
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
ky5 0cytg
28 May 21
Current report (foreign)
6:01am
6-K
l44ks3289r8fg
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
lv2q6p
17 Dec 20
Current report (foreign)
6:01am
6-K
e4lw3vgr sigb7szl7
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
rea90oj p5e
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
20FR12B/A
z3gvs5u2inkt rog1y88
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
5prt3
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
qsnif18edstfg
16 Nov 18
Draft registration statement (amended)
12:00am